CD44 and neoplasm: Quantification of the colony formation assays for both groups showed that the number of colonies was significantly lower after KPT6566 treatment (Figure 5J), indicating that KPT6566 might also be an effective inhibitor of CD44+CD133+ tumor-initiating Caco-2 cells.